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revealed that PLCη2 specifically interacts with LIMK-1 in 
Neuro2A cells. Taken together, these data emphasize the 
importance of the PLCη2 EF-hand domain and articulation 
of PLCη2 with LIMK-1 in regulating neuritogenesis.
Keywords Calcium signaling · Cell differentiation · 
Electron microscopy · Neuritogenesis · Protein–protein 
interaction
Introduction
Phospholipase C (PLC) enzymes are a well-characterized 
family of hydrolytic enzymes (E.C. 3.1.4.11). In mam-
mals, PLC enzymes are responsible for cleaving the mem-
brane phospholipid phosphatidylinositol 4,5-bisphosphate 
(PtdIns(4,5)P2), thereby generating the two essential sec-
ond messengers inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) 
and 1,2-diacylglycerol (DAG) following receptor activa-
tion. Consequently, Ins(1,4,5)P3 triggers calcium discharge 
from the endoplasmic reticulum and DAG together with 
calcium activates effector proteins, most notably protein 
kinase C (PKC; Berridge et al. 1983; Hokin and Hokin 
1953; Streb et al. 1983). Six classes of PLCs have been 
identified based on their amino acid sequence, domain 
structure, and mechanism of activation. These include 
the β, γ, δ, ε, ζ and η classes (Suh et al. 2008). The most 
recently identified is the η class of which there are two iso-
forms, PLCη1 and PLCη2 (Hwang et al. 2005; Nakahara 
et al. 2005; Stewart et al. 2005; Zhou et al. 2005), encoded 
by the PLCH1 and PLCH2 genes, respectively. A number 
of spliceforms of both PLCη1 and PLCη2 exist, which 
vary in length at the C-terminal end (Hwang et al. 2005; 
Zhou et al. 2005). This region is rich in serine and proline 
residues, and it is thought that this part of the protein may 
Abstract Neurite growth is central to the formation 
and differentiation of functional neurons, and recently, an 
essential role for phospholipase C-η2 (PLCη2) in neuri-
togenesis was revealed. Here we investigate the function 
of PLCη2 in neuritogenesis using Neuro2A cells, which 
upon stimulation with retinoic acid differentiate and form 
neurites. We first investigated the role of the PLCη2 cal-
cium-binding EF-hand domain, a domain that is known to 
be required for PLCη2 activation. To do this, we quantified 
neurite outgrowth in Neuro2A cells, stably overexpress-
ing wild-type PLCη2 and D256A (EF-hand) and H460Q 
(active site) PLCη2 mutants. Retinoic acid-induced neu-
ritogenesis was highly dependent on PLCη2 activity, with 
the H460Q mutant exhibiting a strong dominant-negative 
effect. Expression of the D256A mutant had little effect on 
neurite growth relative to the control, suggesting that cal-
cium-directed activation of PLCη2 is not essential to this 
process. We next investigated which cellular compartments 
contain endogenous PLCη2 by comparing immunoelectron 
microscopy signals over control and knockdown cell lines. 
When signals were analyzed to reveal specific labeling for 
PLCη2, it was found to be localized predominantly over the 
nucleus and cytosol. Furthermore in these compartments 
(and also in growing neurites), a proximity ligand assay 
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facilitate protein–protein interactions (Suh et al. 2008). 
Both PLCη enzymes can be activated directly by mobili-
zation of intracellular calcium (Kim et al. 2011; Popovics 
et al. 2011, 2014). We recently reported that mutation of a 
putative calcium-binding residue (D256A) within EF-loop 
1 of the EF-hand domain of PLCη2 reduces the sensitivity 
to calcium by tenfold, indicating this domain to be respon-
sible for calcium-induced activation (Popovics et al. 2014). 
In addition, it has also been shown that PLCη2, but not 
PLCη1, can be activated by Gβγ, which is released from 
trimeric G-protein complexes following G-protein-coupled 
receptor activation (Zhou et al. 2005, 2008).
The isozyme PLCη2 is expressed in neurons with 
highest expression in the olfactory bulb, cerebral cortex 
and pyramidal cells of the hippocampus (Nakahara et al. 
2005). It is also expressed within the habenula, the retina 
(Kanemura et al. 2010), in the pituitary and neuroendo-
crine cells (Stewart et al. 2007) as well as in non-nervous 
tissue such as the intestine and pancreatic islets (Stewart 
et al. 2005). Its specific function(s) within neurons is still 
unclear, although considering its sensitivity toward cal-
cium, it is thought that PLCη2 may act synergistically 
with other PLCs or calcium-activated processes (Popovics 
and Stewart 2012). PLCη2 is expressed in the brain of 
mice after birth and increases until 4 weeks of age. Cul-
tured hippocampal pyramidal cells showed a high level 
of PLCη2, whereas astrocyte-enriched cultures did not 
show any expression (Nakahara et al. 2005), indicating a 
functional role in neuronal formation and physiology. In 
accordance, deletion of the chromosomal region 1p36.32 
in which PLCη2 is located, leads to mental retardation 
(Fitzgibbon et al. 2008; Lo Vasco 2011). Previously, using 
a targeted knockdown approach, we found PLCη2 to be 
essential for retinoic acid-induced neurite growth in Neu-
ro2A cells (Popovics et al. 2013). Despite this, the precise 
mechanism by which PLCη2 facilitates neurite growth in 
these cells is not known. In our previous study, through 
use of a bacterial two-hybrid assay we identified Lim-
domain kinase-1 (LIMK-1) as a putative C-terminal inter-
action partner of PLCη2 (Popovics et al. 2013). LIMK-1 
acts primarily downstream of Rho GTPases to phospho-
rylate and inactivate cofilin family proteins (cofilin1, cofi-
lin2 and destrin), which promote actin depolymerization 
and the severing of actin filaments during neurite out-
growth (Arber et al. 1998; Yang et al. 1998; Endo et al. 
2007). LIMK-1 has also been shown to be a substrate 
for calcium/calmodulin-dependent kinase-IV (CaMKIV) 
during neurite growth (Takemura et al. 2009). Although 
it was revealed that PLCη2 and LIMK-1 do indeed co-
localize in Neuro2A cells (Popovics et al. 2013), it is not 
known whether these two proteins directly interact in the 
cell, or whether such interactions occur during neurite 
outgrowth.
To gain a better understanding of the role of PLCη2 
in neuritogenesis, we examine the importance of PLCη2 
activity and calcium-mediated activation of the enzyme 
for neurite outgrowth in Neuro2A cells stably overexpress-
ing wild-type and mutant PLCη2 proteins. In addition, we 
examine the intracellular localization of PLCη2 in Neu-
ro2A cells at the ultrastructural level and, through use of a 
proximity ligand assay, probe the interaction of PLCη2 and 
LIMK-1 in differentiating Neuro2A cells.
Materials and methods
Growth and retinoic acid‑induced differentiation 
of Neuro2A cells
Neuro2A cells were obtained from the European Collection 
of Cell Cultures (Salisbury, UK). Eagle’s minimal essential 
medium (EMEM) supplemented with 10 % fetal bovine 
serum (FBS), 2 mM l-glutamine and 50 units/ml of peni-
cillin/streptomycin (complete EMEM) was used to main-
tain Neuro2A cells and stable transfected clones. Neuro2A 
cells were differentiated as previously described by Zeng 
and Zhou (2008). Briefly, cells were plated at a low den-
sity (100 cells/mm2) in 6-well plates in complete EMEM 
which was changed to the differentiation medium the next 
day (EMEM with 2 % FBS, 2 mM l-glutamine and 20 µM 
retinoic acid). Medium was replaced every day for 4 days. 
Micrographs showing cells at 4-day differentiation were 
collected by a Zeiss Axiovert 40 CFL microscope with a 
10× objective (Carl Zeiss Ltd., Cambridge, UK). Images 
were taken using an AxioCam ICc 1 digital camera (Carl 
Zeiss Ltd.). Neurite outgrowth was assessed by taking four 
micrographs by random selection from all experimental 
conditions (in each case, at least 220 cells were sampled 
per experiment), and experiments were repeated three 
times. All cells possessing at least one neurite with a length 
at least twice the cell body were considered differentiated. 
Results were expressed as a percentage of differentiated/
total cell number.
Generation of stable Neuro2A cell lines overexpressing 
wild‑type and mutant PLCη2
An expression construct encoding residues 75-1238 of mouse 
PLCη2 (isoform a; NP_780765) in pcDNA3.1 (as used in 
Nakahara et al. 2005) was a gift from Prof. Kiyoko Fukami 
(Tokyo University of Pharmacy and Life Science, Japan). The 
pcDNA3.1-PLCη2 expression construct was used to synthe-
size D256A and H460Q mutants using the Quikchange Site-
Directed Mutagenesis Kit (Stratagene, Amsterdam, The Neth-
erlands). Neuro2A cells were stably transfected with empty 
pcDNA3.1 vector (control) and wild-type and mutant PLCη2 
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expressing plasmids to produce cell lines overexpressing each 
protein. In each case, 20 µg of DNA was transfected by elec-
troporation using a Bio-Rad Gene Pulser (Hertfordshire, UK) 
at 230 V, 950 μF. Stably transfected cells were selected after 
48 h by adding 500 µg/ml G418 (InvivoGen, San Diego, CA, 
USA) and single cell-derived clones were picked and cultured 
for further experiments.
Measurement of PLCH2 mRNA levels in stable 
Neuro2A cell lines
The mRNA expression levels of PLCH2 (OMIM *612836) 
forms in stable Neuro2A cell lines were measured using 
quantitative PCR. Briefly, mRNA was isolated using the 
Isolate RNA Mini Kit (Bioline, London, UK) accord-
ing to the manufacturer’s instructions. DNA contamina-
tion was removed by DNAse digestion (RQ1 RNase-Free 
DNase, Promega, Southampton, UK). This was followed 
by a two-step reverse transcription reaction using 0.5 µg 
of mRNA. The mRNA was incubated with 100 pmol oli-
god T18 and 0.5 mM dNTP in DEPC-treated water at 65 °C 
for 5 min. RevertAid Premium Reverse Transcriptase (200 
units), RiboLock RNase Inhibitor (20 units; Thermo Fisher 
Scientific, Surrey, UK) and 1× RT-buffer (Fermentas, St. 
Leon-Rot, Germany) were added. Mixtures were incu-
bated for 30 min at 50 °C followed by 10 min at 60 °C. 
Reactions were terminated at 85 °C for 5 min. PLCH2 
and RPLP0 mRNA expression levels were detected by 
RT-PCR using primers obtained from Eurofins Scientific 
(Luxembourg). The sequences of corresponding prim-
ers used were: PLCH2, 5′-GGCTACACTCTGACCT 
CCAAGATCC-3′ (forward) and 5′-GGAAGCATGGT 
GGCATCTTCGCTGC-3′ (reverse); RPLP0, 5′-GAGTG 
ATGTGCAGCTGATAAAGACTGG-3′ (forward) and 
5′-CTGCTCTGTGATGTCGAGCACTTCAG-3′ (reverse). 
The RPLP0 primers were used previously as described 
(Popovics et al. 2013). The PLCH2 primers were designed 
in house and checked for specificity using adequate positive 
and negative controls. PCR reactions contained 1× reaction 
buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 250 nM of each 
primer and 1.25 units of GoTaq polymerase (Promega). 
Reactions were cycled at 95 °C for 15 s, 60 °C for 30 s and 
72 °C for 1 min. The expression level of PLCη2 was meas-
ured by qPCR relative to the level of the large ribosomal 
protein P0 (RPLP0) mRNA. Expression was detected by 
Brilliant III Ultra-Fast SYBR Green mix (Agilent Technol-
ogies, Cheshire, UK) using a 7300 Real-Time PCR system 
(Applied Biosystems, Massachusetts, USA). Expression 
levels were calculated by the ΔCt method. At least four col-
onies were chosen from each stably transfected cell group, 
and qPCR analysis was performed simultaneously on their 
cDNA to evaluate the expression of inserted gene. Based 
on the gene expression, colonies that possessed comparable 
levels of PLCH2 in each transfection group were chosen 
for differentiation studies.
Immunogold labeling and electron microscopy (EM)
Samples were processed according to the Tokuyasu thawed 
frozen section method (Tokuyasu 1973). Briefly, Neu-
ro2A cells stably expressing a PLCη2-targetted shRNA 
(PLCη2 KD) or non-target shRNA control (referred to as 
shRNAPLCη2-1 and shRNA control, respectively, in Popo-
vics et al. 2014) were grown to full confluency in a T-75 
flask before fixation with 4 % p-formaldehyde, 0.05 % 
glutaraldehyde, buffered with 0.2 M PIPES, pH 7.2, for 
15 min at ambient temperature. Cells were then scraped, 
collected and centrifuged at 16,000×g for 15 min to form a 
pellet before cryoprotection in 2.3 M sucrose in PBS (over-
night at 4 °C). Small blocks were prepared from the pellets 
and mounted onto specimen carriers before plunge-freezing 
in liquid N2. Sections (80 nm thick) were cut at −100 °C 
(Leica EM FC7 ultracryomicrotome; Vienna, Austria) and 
retrieved using droplets of 2.1 M sucrose:2 % (w/v) methyl 
cellulose (mixed 1:1) and mounted in the same solution on 
pioloform-coated EM copper grids (Agar Scientific, Stan-
stead, UK) and stored at 4 °C. Prior to immunogold labe-
ling, grids were washed three times in ice-cold distilled 
water (5 min each) and once in PBS (5 min) at ambient 
temperature. Sections were then incubated in 0.5 % fish 
skin gelatin (Sigma-Aldrich) in PBS and labeled using a 
custom polyclonal rabbit antibody raised commercially 
against a short peptide of PLCη2 (60 min; SKVEED-
VEAGEDSGVSRQN; EZBiolab, Westfield, IN, USA), fol-
lowed by three washes in PBS (15 min total) and 10 nm 
protein A-gold (20 min; BBI Solutions, Dundee, UK). After 
washing in PBS and distilled water, the sections were con-
trasted using 2 % (w/v) methylcellulose/3 % (w/v) uranyl 
acetate (mixed 9:1), and after air-drying the sections were 
visualized using a JEOL 1200 EX transmission electron 
microscope operated at 80 kV and images observed and 
recorded using an Orius 200 digital camera (Gatan, Abing-
don, UK). Sections from shRNAPLCη2-1 and shRNA con-
trol samples were always run in parallel using the same 
solutions, dilutions and under environmental conditions.
Cell structures were identified according to the following 
criteria: The nuclear envelope was a double membrane that 
separated the nucleus from the cytosol. Mitochondria were 
elongated or circular profiles with double membranes and at 
least one double-membraned crista profile. ER was defined 
as a double-membraned cisterna decorated by ribosomes. 
The plasma membrane was a single membrane layer at the 
cell periphery. The Golgi apparatus cisternal stack was iden-
tified as at least two closely stacked cisternal membranes 
each with an axial ratio of at least 3:1 (groups of vesicu-
lotubular structures were considered as belonging to Golgi 
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if they were closer than two vesicle widths from Golgi cis-
ternal structures). MVBs were round structures containing 
at least one round structure within it. Isolated vesicles were 
small round structures (50–100 nm) within the cytosol.
To analyze specific labeling, the control and knockdown 
preparations were fixed, sectioned and labeled in parallel 
using identical solutions. For quantification, labeled sec-
tions were visualized at a nominal magnification of 5000× 
and analyzed in a series of scans placed systematic uniform 
random (SUR; Lucocq 2008, 2012), across the ribbon of sec-
tions. Gold particles were counted and assigned to different 
cellular compartments. To compare the intensity of labe-
ling, membranes of the endoplasmic reticulum or nuclear 
envelope were used as a standard to which gold labeling of 
various organelles/compartments was related. These stand-
ard membranes were assessed during scanning by counting 
intersections of these membranes with the edge of a marker 
feature that was placed on the display screen. The density 
of gold particles was then expressed as a labeling index by 
dividing the number of gold particles by the membrane inter-
sections. In the case of gold labeling situated over volume 
occupying compartments such as nucleoplasm and cytosol, 
the gold counts were related to the number of nuclear enve-
lope and plasma membrane intersections, respectively.
Proximity ligand assay of PLCη2‑LIMK‑1 interactions
Ligand proximity assays as described by Söderberg et al. 
(2006) were performed using the Duolink proximity 
ligand assay system (Sigma-Aldrich). Two sets of experi-
ments were performed; the first with Neuro2A cells stably 
expressing PLCη2-targeted shRNA and the corresponding 
non-target shRNA-expressing control cells and the sec-
ond, with untransfected Neuro2A cells grown for 4 days 
in the presence and absence of 20 μM retinoic acid. In all 
cases, cells were seeded at a low density (100 cells/mm2) 
and grown on coverslips overnight. The PLA assay was 
performed in accordance with the manufacturer’s instruc-
tions. For specific visualization of the PLCη2-LIMK-1 
interaction in cells, a custom rabbit anti-PLCη2 antibody 
(as described above; 1:100 dilution) and a mouse poly-
clonal anti-LIMK-1 antibody (Abcam, Cambridge, UK; 
1:100 dilution) were used. Samples were analyzed using 
the Leica TCS SP8 confocal microscope with a 63× objec-
tive (Leica Microsystems, Heidelberg, Germany).
Results
PLCη2 activity is important for neurite growth
A characteristic property of PLCη enzymes is their abil-
ity to be directly activated by calcium released from 
intracellular stores (Kim et al. 2011; Popovics et al. 2011). 
To assess the importance of PLCη2 activity in neurite out-
growth and to determine whether calcium-induced activa-
tion of PLCη2 plays a role in this process, Neuro2A cells 
stably overexpressing wild-type PLCη2 and mutant forms 
of the enzyme (D256A and H460Q) were created and 
analyzed together. Neuro2A cells stably transfected with 
empty vector only (EV) were used as a control. The D256A 
mutation has been demonstrated previously to abolish the 
ability of calcium to activate PLCη2 through perturbation 
of calcium binding at EF-loop 1 of the EF-hand domain 
(Popovics et al. 2014). His460 corresponds to a key active 
site residue that is highly conserved within PLC isozymes 
(Heinz et al. 1998), and mutation of the corresponding His 
residue in PLCδ1 (His356) has been shown to abolish the 
activity of this enzyme (Stallings et al. 2005). Quantita-
tive PCR analysis revealed PLCη2 mRNA levels to be 
increased 3–4-fold in all cell lines stably expressing PLCη2 
forms relative to control cells (Fig. 1a). The cell lines 
were treated with retinoic acid for 4 days, and the propor-
tion of cells showing signs of differentiation was assessed 
(Fig. 1b–f). Following retinoic acid treatment, there was a 
slight but significant increase in the average percentage of 
differentiated cells observed in the wild-type PLCη2 stably 
transfected cells (55.9 ± 0.9 %), relative to controls cells 
(49.0 ± 1.1 %), p = 0.0285, n = 3. Conversely, cells sta-
bly transfected with the H460Q mutant exhibited a dra-
matic reduction in the proportion of differentiated cells 
(2.4 ± 0.3 %) relative to control cells after stimulation with 
retinoic acid, p = 0.0003, n = 3. A comparable degree of 
differentiation was observed in the cells stably transfected 
with the D256A mutant (44.9 ± 0.9 %) relative to control 
after the treatment, p = 0.9195, n = 3. Note that errors 
quoted above represent S.E.M from three separate experi-
ments. To reduce the possibility of type 1 errors, p values 
were corrected by applying Bonferroni’s correction.
Immunogold localization of PLCη2 in Neuro2A cells
Because of the compartmentalized nature of cells, deter-
mining a protein’s localization can provide a good indi-
cation of its functional role. Therefore, we examined the 
intracellular localization of endogenous PLCη2 in Neu-
ro2A cells using quantitative immunoelectron microscopy 
(EM). We used two previously generated Neuro2A cell 
lines (Popovics et al. 2013): one stably expressing PLCη2-
targeted shRNA plasmid (PLCη2 KD) and the other a non-
target shRNA (control). As determined by Western blot-
ting, the cell line expressing the PLCη2-targetted shRNA 
plasmid was shown to exhibit a 67 % reduction in PLCη2 
expression at the protein level, and a ninefold reduc-
tion in retinoic acid-induced neuritogenesis after 4 days, 
relative to the control cells (Popovics et al. 2013). The 
Histochem Cell Biol 
1 3
signal intensities over a range of cellular compartments 
were compared as shown in Fig. 2a. The majority of orga-
nelles were found to exhibit a higher signal in the control 
compared with PLCη2 KD cells. The specific percentage 
of gold particles attributed to each organelle was then cal-
culated in order to assess the degree of specific staining 
(Fig. 2b; Table 1). The majority of specific signal, corre-
sponding to the presence of PLCη2, was found in the cell 
nucleus (54.4 ± 3.5 %) and to a lesser degree, the cyto-
sol (27.4 ± 1.4 %) and mitochondria (8.8 ± 2.6 %), A 
smaller specific signal was observed at plasma membrane 
(5.5 ± 1.3 %), nuclear envelope (2.2 ± 1.0 %), endoplas-
mic reticulum (1.7 ± 1.5 %). No specific staining was 
observed over the Golgi apparatus or multivesicular bodies. 
Note that errors quoted above represent S.E.M from three 
separate experiments.
PLCη2 interacts directly with LIMK‑1
LIMK-1 was previously identified as an interaction partner 
of PLCη2 using a bacterial hybrid screen (Popovics et al. 
2013). In order to attempt to clarify the direct interaction 
of PLCη2 with LIMK-1, proximity ligand assays were 
performed using control and PLCη2 KD cells. In each of 
these cell lines, fluorescent particles, corresponding to 
interactions between PLCη2 and LIMK-1, were observed 
and were predominantly located within the cytosol, but 
some were also present in the cell nucleus (Fig. 3a–c). 
Fig. 1  a Graph showing 
mRNA expression levels of 
PLCη2 relative to RPLP0 in 
stably transfected cell lines. 
Error bars represent S.E.M. 
The statistical significance 
was established by one-way 
ANOVA using Tukey’s honest 
significance test. Differences 
in PLCη2 mRNA expression 
(relative to RPLP0 mRNA 
expression) in cell lines stably 
expressing PLCη2 forms were 
nonsignificant as indicated 
by n.s; where p > 0.05. b 
Graph showing percentage 
of differentiation in different 
stable cell lines. Error bars 
represent S.E.M. The statisti-
cal significance (as determined 
by unpaired t test with applied 
Bonferroni’s correction) is 
indicated as ***p < 0.001 and 
*p < 0.05. c–f Representative 
bright-field images of stable 
cells expressing empty vec-
tor (EV), wild-type PLCη2 
(PLCη2) and D256A and 
H460Q mutants, respectively, 
after 4 days of retinoic acid 
treatment. Scale bars corre-
spond to 10 µm
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The number of fluorescent particles in the PLCη2 con-
trol cells was eightfold higher than in PLCη2 KD cells, 
indicating the staining to be specific. The assay was also 
performed with non-transfected Neuro2A cells grown for 
4 days in the presence or absence of 20 μM retinoic acid. 
The retinoic acid-treated Neuro2A cells underwent normal 
differentiation, characterized by an enlargement of the cell 
body and neurite outgrowth (Fig. 3d–h). The number of flu-
orescent particles in retinoic acid-treated cells was approxi-
mately eightfold greater than the untreated cells. Particles 
were observed mainly in the cytoplasm and within grow-
ing neurites, as well as in the nucleus to a lower degree. 
Fig. 2  a Graph showing the labeling index for PLCη2 localization 
over cell compartments and organelles in non-target shRNA control 
cells (black bars) and PLCη2 KD cells (white bars). The index was 
calculated by dividing the number of counted gold particles counted 
over each organelle by the number of intercepts that a set reference 
point made with standard membrane features during scanning. Error 
bars represent S.E.M from three experiments. Filled bars control 
cells and open bars knockdown. b Graph showing the percentage of 
specific gold in each compartment/organelle as derived from Table 1. 
Error bars represent S.E.M from three experiments. Mito mitochon-
dria, PM plasma membrane, ER endoplasmic reticulum, NE nuclear 
envelope, MVB multivesicular body, Golgi Golgi apparatus
Table 1  Data used to calculate the specific percentage of gold particles in cellular compartments/organelles
Specific labeling density was calculated from the difference between control and knockdown. The number of specific gold particles attributed 
to each organelle was calculated as described previously (Lucocq and Gawden-Bone 2010). Briefly, specific density (SD) of gold particles was 
calculated by subtracting the average density of labeling for each organelle in PLCη2 KD Neuro2A cells from that of control cells. SD was then 
divided by the average density in control cells to determine the fraction specific (FS) gold particles. Next, specific gold (SG) was calculated by 
multiplying FS by the total number of raw gold particles counted in each organelle in control cells. This was then divided by the total SG across 
all compartments and multiplied by 100 to establish the percentage of specific gold in each organelle. Data are expressed as average values 
across three experiments
Specific density (SD) Fraction specific (FS) Total raw gold Specific gold (SG) % Specific
Mitochondria 0.16 0.48 25.33 9.59 8.82
Nucleus 1.74 0.72 102.00 71.60 54.38
PM 0.12 0.75 9.67 7.15 5.47
ER 0.04 0.21 19.67 1.23 1.71
Cytosol 0.56 0.57 62.67 35.77 27.38
NE 0.07 0.53 5.00 2.29 2.25
MVB 0.14 0.33 1.00 0.00 0.00
Golgi 0.22 0.22 0.33 0.00 0.00
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These results confirm that PLCη2 and LIMK-1 do indeed 
interact and provide a strong indication that their interac-
tion is important for retinoic acid-induced Neuro2A cell 
differentiation.
Discussion
The Neuro2A cell is an established cell model for the 
examination of molecular events that regulate neuronal 
differentiation (Pankratova et al. 1994; Riboni et al. 1995; 
Carter et al. 2003; Kouchi et al. 2011), and upon stimula-
tion with retinoic acid, they change from a stem cell-like 
morphology to a neuronal one, including formation and 
extension of neurites. An essential role for PLCη2 in neu-
rite growth was previously demonstrated in Neuro2A cells 
(Popovics et al. 2014), which was further investigated 
in this study. Unlike most PLCs which comprise a non-
calcium-sensing EF-hand-like domain (Bairoch and Cox 
1990), PLCη2 has a functional EF-hand domain containing 
Fig. 3  Proximity ligand assay allowing visualization and quantifi-
cation of PLCη2-LIMK-1 interactions in Neuro2A cells. Fluores-
cent images in (a) and (b) are taken from control and PLCη2 KD 
Neuro2A cells, respectively. Fluorescent particles corresponding 
to PLCη2-LIMK-1 interactions appear in red and DAPI-staining of 
nuclei in blue. These micrographs are representative of the quan-
titative data shown in (c). c Graph showing the average number of 
fluorescent particles in each cell for control and PLCη2 KD groups. 
Five images were taken at random locations on the coverslip and 
nuclei and fluorescent particles which indicate PLCη2 interaction 
with LIMK-1 were counted according to a randomized counting 
method. d, e Fluorescent images [representative of quantitation in 
(f)] are taken from untreated and retinoic acid-treated Neuro2A cells, 
respectively (fluorescent particles corresponding to PLCη2-LIMK-1 
interactions appear in red; DAPI-staining of nuclei in blue). f Graph 
showing the average number of fluorescent particles in untreated and 
retinoic acid-treated Neuro2A cells. Five micrographs were taken at 
random. Nuclei and fluorescent particles which indicate PLCη2 inter-
action with LIMK-1 were counted according to a randomized count-
ing method. g, h Respective “close-up” images of the cells in (d, e) as 
indicated, where fluorescence is merged with bright-field view such 
that individual cells can be more easily visualized. Error bars repre-
sent standard error of the coefficient for five micrographs. The sta-
tistical significance (as determined by unpaired t test) is indicated as 
****p < 0.0001. Scale bars correspond to 15 µm
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a canonical 12‐residue loop (EF‐loop 1) (Popovics et al. 
2014). We reported that EF-loop 1 is responsible for activa-
tion of the enzyme by calcium through mutation of D256 
(to Ala), a key calcium-binding residue in this domain, 
which resulted in an apparent ~tenfold reduction in cal-
cium sensitivity in transfected COS-7 cells (Popovics et al. 
2014). In an attempt to assess both whether PLCη2 activity 
is important for neurite growth and whether such involve-
ment may be due to activation by calcium, we generated 
Neuro2A cells stably overexpressing wild-type PLCη2 and 
mutant forms of the enzyme (D256A and H460Q). Follow-
ing retinoic acid treatment, there was a slight but significant 
increase in the percentage of differentiated cells observed 
in the wild-type PLCη2 stably transfected cells, relative to 
controls cells. Conversely, cells stably transfected with the 
H460Q mutant exhibited a dramatic reduction in the pro-
portion of differentiated cells (~25-fold) relative to control 
cells after stimulation with retinoic acid. A comparable 
degree of differentiation was observed in the cells stably 
transfected with the D256A mutant relative to control 
after the treatment. These results reveal that expression of 
the H460Q mutant has a strong dominant-negative effect 
on neurite outgrowth. These results further highlight the 
essential role of PLCη2 in neurite outgrowth. In addition, 
they suggest that modulation of PLCη2 activity by calcium 
binding at the EF-hand domain may enhance, presum-
ably through positive feedback of calcium signaling, but is 
not essential to retinoic acid-stimulated neurite growth. It 
is therefore likely that the principal mechanism by which 
PLCη2 is activated is not through calcium binding, but 
through another unknown mechanism. Recently, a new role 
has emerged for PLCη2 in secretion of cytoplasmic dense 
core vesicles in neuroendocrine cells. This is accomplished 
by PLCη2-mediated PtdIns(4,5)P2 hydrolysis following its 
activation by Ca2+. The decrease in PtdIns(4,5)P2 causes 
dysregulation of actin binding proteins which results in 
F-actin disassembly, thereby removing the physical barrier 
which would otherwise prevent dense core vesicle up-regu-
lation to the plasma membrane (Yamaga et al. 2015). In this 
process, reorganization of the actin cytoskeleton is there-
fore dependent on Ca2+ activation of PLCη2. The authors 
did, however, show that this occurs only when intracellular 
Ca2+ levels are very high (~800 nM), and showed exocyto-
sis of plasma membrane dense core vesicles at lower Ca2+ 
levels (~400 nM). This suggests that Ca2+ activation of 
PLCη2 may be involved in actin reorganization under cer-
tain conditions that significantly elevate intracellular Ca2+ 
levels.
To establish where in Neuro2A cells PLCη2 is specifi-
cally located, we examined the subcellular localization of 
endogenous PLCη2 by quantitative immuno-EM. This 
approach revealed the majority of endogenous PLCη2 
to reside in the nucleus. We also observed a relatively 
high degree of PLCη2 to be present in the cytosol and to 
a lower extent, at the plasma membrane. The presence of 
PLCη2 in the nucleus and cytosol is consistent with pre-
vious immunofluorescent studies which also revealed 
a high degree of nuclear staining, corresponding to the 
presence of PLCη2, in these cells (Popovics et al. 2011). 
The PH domain of PLCη2 has been shown to bind phos-
phatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) with 
high affinity, a phospholipid which is abundant in Neu-
ro2A cell nuclei (Popovics et al. 2011). Indeed PLCη2 and 
PtdIns(3,4,5)P3 were shown to co-localize in these cells to 
a large degree (Popovics et al. 2011), and hence this inter-
action could govern the cellular localization of PLCη2. If 
so, then it is also likely that PLCη2 resides in the nucleus 
of neuronal cells as they have also been reported to possess 
high levels of PtdIns(3,4,5)P3 in their nuclei (Neri et al. 
1999; Kwon et al. 2010). The presence of other phospho-
lipases such as PLCγ1, PLCδ4 and PLCβ1 in eukaryotic 
cell nuclei is well established (Martelli et al. 1992; Dive-
cha et al. 1993; Matteucci et al. 1998; Ye et al. 2002; Liu 
et al. 1996). PLCβ1 is perhaps the best characterized of 
these and has proposed roles in mediating differentiation 
of C2C12 myoblasts (Faenza et al. 2003) and erythroleu-
kemia cells (Fiume et al. 2005), mainly through regula-
tion of gene expression. It is therefore possible that PLCη2 
plays a similar role in neuronal differentiation. Evidence 
for a role in regulation of gene expression is supported by 
the observation that activation of retinoic acid response 
element (RARE)-associated gene expression is dramati-
cally reduced in PLCη2 KD cells (Popovics et al. 2011). 
As with the cytoplasm, PLCη2 may also be responsible for 
regulating actin dynamics in the nucleus. Although β-actin 
has been identified in the nucleus, actin filaments have not 
been detected at interphase by common F-actin detecting 
methods (Sellers 2004). It has, however, been reported that 
~20 % of nuclear actin forms polymeric structures, with 
rapid turnover (McDonald et al. 2006). Both cofilin and 
LIMK-1 possess nuclear localization sequences and are 
present in the nucleus (Abe et al. 1993; Goyal et al. 2006). 
More recently, it has emerged that cofilin is required for 
RNA polymerase II functioning and transcription elonga-
tion (Obrdlik and Percipalle 2011). It is therefore likely 
that PLCη2 is involved in regulating gene expression and 
actin-related processes in the nucleus; however, the precise 
role of nuclear PLCη2 remains to be established and must 
be probed further.
Another potential mechanism by which PLCη2 may 
contribute to neurite growth is through regulation of 
cytoskeletal dynamics. LIMK-1, a specific regulator of 
actin polymerization, was previously identified using a 
bacterial-2-hybrid screen as a putative interaction partner 
of PLCη2; however, a specific interaction of these two pro-
teins within the cell was not shown (Popovics et al. 2011). 
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It is well established that LIMK-1 deactivates cofilin family 
proteins by phosphorylation, which in turn prevents actin 
depolymerization and contributes to reorganization of the 
actin cytoskeleton (Ghosh et al. 2004; Lorenz et al. 2004). 
Accordingly, neurons from LIMK-1 knockout mice show 
reduced or deficient growth cones as well as abnormal den-
dritic morphology, synapse structures and spine develop-
ment which manifest in behavioral changes such as the re-
learning of spatial information (Meng et al. 2002). LIMK-1 
also appears to have contradictory roles; activation of 
LIMK-1 by Semaphorin 3A (Aizawa et al. 2001), or fibril-
lar amyloid beta (Heredia et al. 2006) for example, leads to 
growth cone collapse and neurite deformation, respectively. 
Based on these studies, it appears that LIMK-1 is an essen-
tial protein for correct central nervous system development, 
but its regulation is important for normal physiology and 
alterations to its normal functioning leads to human dis-
eases such as William’s syndrome, which is characterized 
by mild to moderate mental retardation (Meyer-Lindenberg 
et al. 2006).
To establish whether PLCη2 and LIMK-1 interact 
directly, we utilized a proximity ligand interaction assay 
which allowed quantification and localization of interac-
tions between the two proteins. To attain a positive sig-
nal using this approach, proteins must be in the proxim-
ity of <30–40 nm; this distance is a good indication that 
proteins are close enough to one another to interact, or at 
the very least, participate in cross talk. By looking at com-
piled Z-stack images, we were able to determine that this 
putative interaction took place mainly in the cytosol and 
within growing neurites, suggestive of a role in regulat-
ing actin dynamics. Putative PLCη2-LIMK-1 interactions 
were also observed in the nucleus, albeit to a lower degree. 
Accordingly, LIMK-1 has a nuclear localization signal 
which drives translocation into the nucleus, and shuttling 
between the nucleus and the cytoplasm is indicated by 
presence of nuclear import and export sequences (Goyal 
et al. 2006). Upon cell differentiation, we observed a ~six-
fold increase in fluorescent particles in Neuro2A cells, 
suggesting that these proteins interact to a higher degree 
during differentiation. This may in part be due the fact that 
PLCη2 protein expression is increased in Neuro2A cells 
following retinoic acid treatment (Popovics et al. 2013). 
Some evidence that PLCη2 activation occurs upstream 
from LIMK-1 comes from the observation that phospho-
rylation of LIMK-1 and CREB, a substrate of LIMK-1, 
is significantly reduced in retinoic acid-treated PLCη2 
KD cells relative to control cells (Popovics et al. 2013). 
Also down-regulation of either of these genes significantly 
decreases neurite outgrowth in cultured cells (Endo et al. 
2007; Popovics et al. 2013).
We previously proposed a model by which PLCη2 
may regulate neuronal differentiation (Popovics et al. 
2011), whereby the generation of secondary messengers, 
Ins(1,4,5)P3 and DAG impact upon cytoskeletal dynam-
ics and gene expression, respectively. PLCη2 can be acti-
vated by Gβγ dimers, but as retinoic acid acts upon nuclear 
receptors rather than GPCRs, it would seem unlikely that 
the enzyme is activated this way in the current context. 
PLC isozymes such as PLCδ1 can be activated by kinases 
(Fujii et al. 2009), of which PLCη2 may also be a target. 
It is in theory possible that PLCη2 may be activated by 
LIMK-1; however, without knowledge of a specific activat-
ing phosphorylation site on PLCη2, this will be difficult to 
establish.
Upon PLCη2 activation, the level of PtdIns(4,5)P2 will 
likely decrease with subsequent elevations in Ins(1,4,5)
P3 and DAG. Ins(1,4,5)P3 triggers calcium release from 
the intracellular stores to activate CaMKIV. The conse-
quent stimulation of LIMK-1 activity leads to activation 
of CREB which initiates transcription of genes direct-
ing neuronal differentiation (Popovics et al. 2013). Here, 
we have clarified part of this model by demonstrating the 
direct association of PLCη2 and LIMK-1 in differentiating 
Neuro2A cells. This direct association could allow PLCη2 
to directly activate LIMK-1 by promoting an active con-
formation upon association, or it is possible that this inter-
action simply allows PLCη2 to be “on hand” to modulate 
LIMK-1 activation via Ins(1,4,5)P3 release and CaMKIV 
activation. Changes in the nuclear DAG and PtdIns(4,5)P2 
levels may also influence transcriptional activity through 
modulation of DAG-PKC or PtdIns(4,5)P2-chromatin 
interactions.
In conclusion, we reveal that PLCη2 activity in Neu-
ro2A cells is important for retinoic acid-induced neur-
ite growth but is not dependent upon calcium binding at 
EF-loop 1, highlighting the fact that activation of PLCη2 
during this process does not primarily occur through cal-
cium binding, but via another unknown mechanism. We 
also demonstrate that PLCη2 is present in the nucleus 
and cytosol of Neuro2A cells and reveal that the enzyme 
interacts directly with LIMK-1 in the cytosol and within 
growing neurites as well as inside the nucleus. This inter-
action has important implications for regulation of actin 
dynamics and expression of genes implicated in neuronal 
differentiation.
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